siRNA and CRISPR/single guide RNA (sgRNA) treatment.

WM Wenjuan Ma
YW Yanling Wang
RZ Rongxin Zhang
FY Fan Yang
DZ Duo Zhang
MH Menggui Huang
LZ Lin Zhang
JD Jay F. Dorsey
ZB Zev A. Binder
DO Donald M. O’Rourke
JF Joseph A. Fraietta
YG Yanqing Gong
YF Yi Fan
ask Ask a question
Favorite

ECs were transfected with non-targeting control siRNA (Qiagen (1027280) or Thermo Fisher Scientific (AM4611)) or with siRNAs targeting Snail (Thermo Fisher Scientific; s13185), Slug (Thermo Fisher Scientific; s13127), ZEB1 (Thermo Fisher Scientific; s229971 or 4392420), MEF2D (Dharmacon; L-009884-00-0005), LEF1 (Dharmacon; L-015396-00-0005), PPAR-γ (Dharmacon; L-003436-00-0005) or PAK4 (Thermo Fisher Scientific; s20134 or 4390824) using RNAiMAX Lipofectamine (Invitrogen; 13778075) in serum-free Opti-MEM medium (Gibco; 31985-070) for 12 h, followed by incubation with serum-supplemented medium for 24 h. The guide RNA sequence (5′-GTGTTTGGGAAGAGGAAGAAG-3′) targeting PAK4 was subcloned into lentiCRISPRv2 puro vector (Addgene; 52961). ECs were transduced with the lentivirus expressing PAK4 sgRNA, followed by cell selection by incubation with medium containing 2 μg ml−1 puromycin.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A